Related Experiment Video
Updated: May 17, 2026

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Targets, trafficking, and timing of cardiac autophagy
David Rotter1, Beverly A Rothermel
1The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
Insights
Autophagy, a cellular recycling process, is increasingly recognized as a therapeutic target for heart failure. However, its complex role in cardiac health requires careful consideration for effective drug development.
Area of Science:
- Cardiology
- Cellular Biology
- Biochemistry
Background:
- Heart failure is a leading cause of death globally, with increasing prevalence.
- Autophagy is a critical cellular process for recycling and repairing intracellular components.
- Cardiac autophagic activity is elevated in various disease states, suggesting its involvement in heart conditions.
Purpose of the Study:
- To explore the potential of autophagy as a therapeutic target for cardiovascular disease and heart failure.
- To address the challenges posed by the dual role of cardiac autophagy in disease progression.
- To identify opportunities for optimizing pharmacological interventions targeting autophagy.
Main Methods:
- Review of existing human and animal model studies on cardiac autophagy.
- Analysis of regulatory control points in autophagic activity and cargo selection.
- Investigation into the circadian regulation of systemic autophagy.
Main Results:
- Cardiac autophagy plays a complex, dual role, sometimes beneficial and sometimes detrimental to cardiac function.
- Multiple regulatory pathways offer diverse targets for drug development.
- The circadian rhythm of autophagy presents a potential, often overlooked, factor for optimizing treatment timing.
Conclusions:
- Autophagy modulation holds promise for heart failure treatment, but its complex nature must be navigated.
- Targeting specific control points and considering circadian rhythms could enhance therapeutic efficacy.
- Further research is needed to fully harness autophagy's potential in cardiovascular medicine.
Abstract:
Heart failure is the major case of death in developed countries, and its prevalence is growing worldwide. Autophagy is a fundamental cellular mechanism through which intracellular components can be removed, recycled and repaired. Studies in humans and animal models demonstrate a marked increase in cardiac autophagic activity under a wide range of disease states and in response to diverse stimuli. Recently, autophagy has been widely promoted as a potential therapeutic target for the treatment of cardiovascular disease and heart failure. An important challenge to achieving this goal is the dual nature of cardiac autophagy, sometimes acting to help preserve cardiac function, other times appearing to promote cardiac decline. Numerous control points regulating autophagic activity and cargo selection provide a diversity of opportunities for drug targeting. In addition there is an innate circadian rhythm to the systemic regulation of autophagy that is often overlooked but provides potential opportunities to target and optimize pharmacological intervention.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Cellular Injury V: Apoptosis and Autophagy
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

